3/4/2014

The FDA has granted AstraZeneca approval for its Bydureon pen, 2 milligrams, to help bolster glycemic control in adult type 2 diabetes patients. The pen is to be used as an add-on to diet and exercise.

Full Story:
Drug Store News

Related Summaries